Abbott slumps over 8% after missing Q4 revenue targets, lower Q1 forecast
Abbott Laboratories stock slumped on Thursday following the firm’s projection of first quarter earnings beneath Wall Street forecasts and its failure to meet revenue targets for the fourth quarter. The medical device maker announced it anticipates first quarter adjusted profits per share between $1.12 and $1.18, trailing the consensus Wall Street projection of $1.19 per…

